Drug Shortage Report for DEXAMETHASONE-OMEGA

Last updated on 2026-01-06

Report ID 272781
Drug Identification Number 02204266
Brand name DEXAMETHASONE-OMEGA
Common or Proper name Dexamethasone Sodium Phosphate Injection USP 4 mg/mL
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE PHOSPHATE
Strength(s) 4MG
Dosage form(s) LIQUID
Route of administration SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Packaging size 5 x 5mL vial / fiole
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-11-26
Estimated end date 2026-02-27
Actual end date
Shortage status Actual shortage
Updated date 2026-01-06
Company comments The product is on allocation
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2026-01-06 French Compare
v8 2026-01-06 English Compare
v7 2025-12-30 French Compare
v6 2025-12-30 English Compare
v5 2025-12-22 French Compare
v4 2025-12-22 English Compare
v3 2025-11-27 French Compare
v2 2025-11-27 English Compare
v1 2025-11-27 English Compare

Showing 1 to 9 of 9